Human metapneumovirus (HMPV) is a respiratory virus that primarily affects the respiratory system, particularly in young children, older adults, and individuals with weakened immune systems. It belongs to the Paramyxoviridae family, closely related to respiratory syncytial virus (RSV). HMPV is a leading cause of upper and lower respiratory tract infections, including bronchiolitis, pneumonia, and acute respiratory distress.
Key Features:
- Transmission: Spread through respiratory droplets, direct contact with contaminated surfaces, or close contact with infected individuals.
- Symptoms: Includes cough, fever, nasal congestion, wheezing, and difficulty breathing. Severe cases may lead to hospitalization, particularly in vulnerable populations.
- Seasonality: Outbreaks often occur during late winter to early spring, similar to other respiratory viruses.
- Diagnosis: Typically confirmed through PCR tests, viral cultures, or antigen detection from respiratory specimens.
- Treatment: Supportive care, such as oxygen therapy or hydration, as there is no specific antiviral treatment or vaccine available.
- Prevention: Good hygiene practices, such as frequent handwashing, avoiding close contact with sick individuals, and disinfecting surfaces, can reduce the risk of infection.
HMPV remains a significant cause of respiratory illness worldwide, emphasizing the importance of early detection and appropriate care.
